跳至主要内容
临床试验/IRCT20190112042329N1
IRCT20190112042329N1招募中2 期

A clinical trial on the effectiveness of intracoronary adenosine for the prevention of no-reflow phenomenon in patients with acute myocardial infarction

Mashhad University of Medical Sciences0 个研究点目标入组 126 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
126

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 no limit(—)
性别
All

入选标准

  • Age higher than 20 years
  • An elapse of 12 hours form the primary diagnosis

排除标准

  • Having chronic obstructive pulmonary disease, asthma, less than 90 mm Hg systolic blood pressure, cardiac arrhythmia, sick sinus syndrome and neuropathy
  • Candidates for coronary artery bypass grafts
  • Using other medicines, such as verapamil

研究者

相似试验

Effect of intracoronary adenosine in patients with... | 临床试验